Crystal structures of enoyl-ACP reductases i (FabI) and III (FabL) from B. subtilis

Journal of Molecular Biology

Volumn 406, Issue 3, 2011, Pages 403-415

  Kim, Kook Han ^a,b   Ha, Byung Hak ^a   Kim, Su Jin ^a   Hong, Seung Kon ^a   Hwang, Kwang Yeon ^b   Kim, Eunice Eunkyeong ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea University   (South Korea)

Author keywords

crystal structure; enoyl ACP reductase; FabI; FabL; fatty acid biosynthesis

Indexed keywords

ALCOHOL DEHYDROGENASE; ENOYL ACYL CARRIER PROTEIN REDUCTASE 1; ENOYL ACYL CARRIER PROTEIN REDUCTASE 3; OXIDOREDUCTASE; TETRAMER; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BACILLUS SUBTILIS; CATALYSIS; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME MECHANISM; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FAMILY; PROTEIN STRUCTURE;

BACILLUS SUBTILIS;

EID: 79551681011     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.12.003     Document Type: Article

References (48)

1. Campbell J.W., and Cronan J.E. Jr Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery Annu. Rev. Microbiol. 55 2001 305 332
2. Heath R.J., White S.W., and Rock C.O. Lipid biosynthesis as a target for antibacterial agents Prog. Lipid Res. 40 2001 467 497
3. Payne D.J. The potential of bacterial fatty acid biosynthetic enzymes as a source of novel antibacterial agents Drug News Perspect. 17 2004 187 194
4. Cronan J.E. Jr The structure of mammalian fatty acid synthase turned back to front Chem. Biol. 11 2004 1601 1602
5. White S.W., Zheng J., Zhang Y.M., and Rock C.O. The structural biology of type II fatty acid biosynthesis Annu. Rev. Biochem. 74 2005 791 831
6. McMurry L.M., Oethinger M., and Levy S.B. Triclosan targets lipid synthesis Nature 394 1998 531 532
7. Heath R.J., Yu Y.T., Shapiro M.A., Olson E., and Rock C.O. Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis J. Biol. Chem. 273 1998 30316 30320
8. Musser J.M., Kapur V., Williams D.L., Kreiswirth B.N., van Soolingen D., and van Embden J.D. Characterization of the catalase-peroxidase gene (katG) and INHA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance J. Infect. Dis. 173 1996 196 202
9. Heath R.J., and Rock C.O. Regulation of fatty acid elongation and initiation by acyl-acyl carrier protein in Escherichia coli J. Biol. Chem. 271 1996 1833 1836
10. Levy C.W., Roujeinikova A., Sedelnikova S., Baker P.J., Stuituje A.R., Rice D.W., and Rafferty J.B. Molecular basis of triclosan activity Nature 298 1999 383 384
11. Banerjee A., Dubnau E., Quemard A., Balasubramanian V., Um K.S., and Wilson T. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis Science 263 1994 227 230
12. Ling L.L., Xian J., Ali S., Geng B., Fan J., and Mills D.M. Identification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductase Antimicrob. Agents Chemother. 48 2004 1541 1547
13. Payne D.J., Miller W.H., Berry V., Brosky J., Burgess W.J., and Chen E. Discovery of a novel and potent class of FabI-directed antibacterial agents Antimicrob. Agents Chemother. 46 2002 3118 3124
14. Sivaraman S., Sullivan T.J., Johnson F., Novichenok P., Cui G., Simmerling C., and Tonge P.J. Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogues J. Med. Chem. 47 2004 509 518
15. Rafferty J.B., Simon J.W., Baldock C., Artymiuk P.J., Baker P.J., and Stuitje A.R. Common themes in redox chemistry emerge from the X-ray structure of oil seed rape (Brassica napus) enoyl acyl carrier protein reductase Structure 3 1995 927 938
16. Stewart M.J., Parikh S., Xiao G., Tonge P.J., and Kisker C. Structural basis and mechanism inhibition by triclosan J. Mol. Biol. 290 1999 859 865
17. Baldock C., Rafferty J.B., Sedeinikova S.E., Baker P.J., Stuitje A.R., and Slabas A.R. A mechanism of drug action revealed by structural studies of enoyl reductase Science 274 1996 2107 2110
18. Rozwarski D.A., Grant G.A., Barton D.H., Jacobs W.R., and Sacchettini J.C. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis Science 279 1998 98 102
19. Lee H.H., Moon J., and Suh S.W. Crystal structure of the Helicobacter pylori enoyl-acyl carrier protein reductase in complex with hydroxydiphenyl ether compounds, triclosan and diclosan Proteins 69 2007 691 694
20. Freundlich J.S., Wang F., Tsai H.C., Kuo M., Shieh H.M., and Anderson J.W. X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy J. Biol. Chem. 282 2007 25436 25444
21. Lu H., England K., Am Ende C., Truglio J.J., Luckner S., and Reddy B.G. Slow-onset inhibition of the FabI enoyl reductase from Francisella tularensis: residence time and in vivo activity ACS Chem. Biol. 4 2009 221 231
22. Priyadarshi A., Kim E.E., and Hwang K.Y. Structural insights into Staphylococcus aureus enoyl-ACP reductase (FabI), in complex with NADP and triclosan Proteins 78 2010 480 486
23. Heath R.J., and Rock C.O. A triclosan-resistant bacterial enzyme Nature 406 2000 145 146
24. Marrakchi H., Dewolf W.E. Jr., Quinn C., West J., Polizzi B.J., and So C.Y. Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK) Biochem. J. 370 2003 1055 1062
25. Heath R.J., Su N., Murphy C.K., and Rock C.O. The enoyl-[acyl-carrier- protein] reductases FabI and FabL from Bacillus subtilis J. Biol. Chem. 275 2000 40128 40133
26. Seefeld M.A., Miller W.H., Newlander K.A., Burgess W.J., DeWolf W.E. Jr., and Elkins P.A. Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK J. Med. Chem. 46 2003 1627 1635
27. Kavanagh K.L., Jörnvall H., Persson B., and Oppermann U. The SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes Cell Mol. Life Sci. 65 2008 3895 3906
28. Massengo-Tiass R.P., and Cronan J.E. Diversity in enoyl-acyl carrier protein reductases Cell. Mol. Life Sci. 66 2009 1507 1517
29. Kim S.J., Ha B.H., Kim K.H., Hong S.K., Shin K.J., Suh S.W., and Kim E.E. Dimeric and tetrameric forms of enoyl-acyl carrier protein reductase from Bacillus cereus Biochem. Biophys. Res. Commun. 200 2010 517 522
30. Holm L., and Rosenström P. Dali server: conservation mapping in 3D Nucleic Acids Res. 38 2010 W545 W549
31. Zaccai N.R., Carter L.G., Berrow N.S., Sainsbury S., Nettleship J.E., and Walter T.S. Crystal structure of a 3-oxoacyl-(acylcarrier protein) reductase (BA3989) from Bacillus anthracis at 2.4-Å resolution Proteins 70 2008 562 567
32. Fisher M., Kroon J.T., Martindale W., Stuitje A.R., Slabas A.R., and Rafferty J.B. The X-ray structure of Brassica napus β-keto acyl carrier protein reductase and its implications for substrate binding and catalysis Structure 8 2000 339 347
33. + and pseudotropine at 1.9 Å resolution: implication for stereospecific substrate binding and catalysis Biochemistry 38 1999 7630 7637
34. Tipparaju S.K., Mulhearn D.C., Klein G.M., Chen Y., Tapadar S., and Bishop M.H. Design and synthesis of aryl ether inhibitors of the Bacillus anthracis enoyl-ACP reductase Acc. Chem. Res. 41 2008 11 20
35. Xu H., Sullivan T.J., Sekiguchi J., Kirikae T., Ojima I., and Stratton C.F. Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureus Biochemistry 47 2008 4228 4236
36. Price A.C., Zhang Y.M., Rock C.O., and White S.W. Cofactor-induced conformational rearrangements establish a catalytically competent active site and a proton relay conduit in FabG Structure 12 2004 417 428
37. Kim K.H., Park J.K., Ha B.H., Moon J.H., and Kim E.E. Crystallization and preliminary X-ray crystallographic analysis of enoyl-ACP reductase III (FabL) from Bacillus subtilis Acta Crystallogr. F 63 2007 246 248
38. Guerro S.A., Hecht H.J., Hofmann B., Biebl H., and Singh M. Production of selenomethionine-labelled proteins using simplified culture conditions and generally applicable host/vector systems Appl. Microbiol. Biotechnol. 56 2001 718 723
39. Bergler H., Wallner P., Ebeling A., Leitinger B., Fuchsbichler S., and Aschauer H. Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli J. Biol. Chem. 269 1994 5493 5496
40. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 276 1997 307 326
41. Collaborative Computing Project 4 The CCP4 suite: programs for protein crystallography Acta Crystallogr., Sect D: Biol Crystallogr. 50 1994 760 763
42. Qiu X., Janson C.A., Court R.I., Smyth M.G., Payne D.J., and Abdel-Meguid S.S. Molecular basis for triclosan activity involves a flipping loop in the active site Protein Sci. 8 1999 2529 2532
43. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D: Biol Crystallogr. 60 2004 2126 2133
44. Brunger A.T., Adams P.D., Clore G.M., deLano W.L., Gros P., and Grosse-Kunstlever R.W. Crystallography & NMR system: a new software suite for macromolecular structure determination Acta Crystallogr., Sect. D: Biol Crystallogr. 54 1998 905 921
45. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structure by the maximum-likelihood method Acta Crystallogr., Sect. D: Biol Crystallogr. 53 1997 240 255
46. Laskowski R.A., MacArthur M.W., Moss D.S., and Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures J Appl Crystallogr. 26 1993 283 291
47. DeLano W.L. The PyMOL Molecular Graphics System 2004 DeLano Scientific San Carlos, CA
48. Terwilliger T.C SOLVE and RESOLVE: automated structure solution, density modification and model building J. Synchrotron Radiat. 11 2004 49 52